Bioxytran Completes Production of Two Dietary Supplements: V-LO® for Immune Health and A-SUQAR® for Healthy Blood Sugar
Bioxytran has completed production of finished inventory for its first two consumer dietary supplements, V-LO® for immune support and A-SUQAR® for healthy blood sugar. The company is finalizing go-to-market plans across e-commerce, retail, and distribution channels, with launch timing to be announced later; A-SUQAR® is already covered by a February 2026 distribution agreement with Khoury Medical LTD for the Middle East.
Key figures
- Glucose mgmt market cagr
- 6.4%
- Immune health market cagr
- 9.12%
- Glucose mgmt market 2025 usd
- USD 9.9 billion
- Glucose mgmt market 2032 usd
- USD 15.4 billion
- Immune health market 2026 usd
- USD 40.0 billion
- Immune health market 2032 usd
- USD 67.79 billion
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.